Graft-versus-leukaemia effect post fludarabine, melphalan and alemtuzumab reduced intensity allogeneic stem cell transplantat in HIV-infected patient with acute myeloid leukaemia

Graft-versus-leukaemia effect post fludarabine, melphalan and alemtuzumab reduced intensity allogeneic stem cell transplantat in HIV-infected patient with acute myeloid leukaemiaGraft-versus-leukaemia effect post fludarabine, melphalan and alemtuzumab reduced intensity allogeneic stem cell transplantat in HIV-infected patient with acute myeloid leukaemia, Published online: 16 August 2018; doi:10.1038/s41409-018-0297-zGraft-versus-leukaemia effect post fludarabine, melphalan and alemtuzumab reduced intensity allogeneic stem cell transplantat in HIV-infected patient with acute myeloid leukaemia

Source: Bone Marrow Transplantation - August 16, 2018 Category: Hematology Authors: A. Kanellopoulos M. Kaparou E. Xenou S. Paneesha B. Kishore R. Lovell K. Holder J. Suhr L. Baker L. Ryan E. Nikolousis Source Type: research